Is a complete ASX/IXC research report available?

No complete published report is available for asx/IXC (ASX/IXC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/IXC (ASX/IXC)

Australian Securities Exchange: ASX/IXC · AUD

A$0.12

+0.00 (0.0%)· Recorded snapshot

Market cap	8.6M
Revenue (ttm)	46.8K
Net income (ttm)	-1.4M
EPS (ttm)	-A$0.02
Shares out	75.2M
Volume	54
Beta	0.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 46.8K
Net income (ttm): -1.4M
EPS (ttm): -A$0.02
Market cap: 8.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-12 02:00 UTC

All ASX/IXC indicators

Market & fundamental data

Available fields

152

Groups with data

Currency

AUD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 4.6M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	26.12
Isin	AU0000048621
Last refreshed	2026-09-12
Market cap	AUD 8.6M
Price	AUD 0.12
Price currency	AUD
Sector	Healthcare
Sector PE Fwd	31.59
Sic	2834
Symbol	asx/IXC
Website	https://www.invextherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.65%
EV/Sales	98.8x
P/B ratio	2.21x
P/S ratio	184.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	AUD 46,826
Gross Profit Growth	-79.56%
Gross Profit Growth Q	-79.56%
Gross Profit Growth3 Y	-53.28%
Net Income	AUD -1.4M
Net Income Growth Years	0%
Pretax Margin	-2,888.04%
ROA	-19.64
Roa5y	-13.01
ROCE	-38.3
ROE	-29.54
Roe5y	-18.94
ROIC	-20.44

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	18.57%
Cagr3y	28.04%
Cagr5y	-7.46%
EPS Growth Years	0
Revenue Growth	-79.56x
Revenue Growth Q	-79.56x
Revenue Growth Years	0x
Revenue Growth3 Y	-53.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.01
Assets	AUD 4.1M
Cash	AUD 4M
Current Assets	AUD 4.1M
Current Liabilities	AUD 153,471
Debt	AUD 0
Equity	AUD 3.9M
Liabilities	AUD 153,471
Long Term Assets	AUD 0
Long Term Liabilities	AUD 0
Net Cash	AUD 4M
Net Cash By Market Cap	AUD 46.47
Net Cash Growth	-25.28%
Net Debt Equity	AUD -1.03
Tangible Book Value	AUD 3.9M
Tangible Book Value Per Share	AUD 0.05
WACC	7.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	26.48
Net Working Capital	AUD -106,141
Quick ratio	26.48
Working Capital	AUD 3.9M
Working Capital Turnover	AUD 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.74%
Dividend per share	AUD 0
Last Dividend	AUD 0.19

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	18.56%
200-day SMA	0.11
3Y total return	109.92%
50-day SMA	0.11
50-day SMA vs 200-day SMA	50over200
5Y total return	-32.13%
All Time High	2.05
All Time High Change	-94.39%
All Time High Date	2020-05-22
All Time Low	0.06
All Time Low Change	94.92%
All Time Low Date	2025-03-13
ATR	0.01
Beta	0.54
Beta1y	-0.22
Beta2y	-0.16
Ch YTD	-4.17
High	0.12
High52	0.18
High52 Date	2025-09-23
High52ch	-36.11%
Low	0.12
Low52	0.09
Low52 Date	2026-06-30
Low52ch	27.78%
Ma50ch	1.23%
Price vs 200-day SMA	1.95%
RSI	49.77
RSI Monthly	46.61
RSI Weekly	50.99
Sharpe ratio	1x
Sharpe Ratio3y	0.46x
Sharpe Ratio5y	0.15x
Sortino ratio	1.77
Sortino Ratio3y	0.79
Sortino Ratio5y	0.31
Total Return	0.74%
Tr YTD	-4.17
Tr1w	9.52%
Tr3m	4.55%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45,677,206%
Shares Insiders	28.04%
Shares Institutions	21.05%
Shares Out	75,153,848
Shares Qo Q	-0.51%
Shares Yo Y	-0.74%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	52,079.4x
Bv Per Share	0.05
Ch1w	9.52
Ch1y	18.56
Ch3m	4.55
Ch3y	-46.51
Ch5y	-82.71
Ch6m	-4.17
Change	0%
Change From Open	0
Close	0.12
Days Gap	0
Dollar Volume	6.21
Earnings Date	2026-10-27
EBIT	AUD -1.5M
EPS	AUD -0.02
F Score	1
Fiscal Year End	June
Founded	2,019
Investing CF	-2,500,000
Is Primary Listing	1
Last Earnings Date	2026-02-05
Last Report Date	2026-06-30
Ma150	0.12
Ma150ch	-2.62%
Ma20	0.12
Ma20ch	-1.71%
Net CF	-3,858,850
Next Earnings Date	2026-10-27
Open	0.12
Price Date	2026-09-09
Ptbv Ratio	2.21
Relative Volume	0x
Revenue	46,826x
Tr6m	-4.17%
Volume	54
Z Score	26.41

ASX/IXC (ASX/IXC)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/IXC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/IXC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ASX/IXC

Frequently asked questions